2
|
Zhang X, Li X, Sivaguru P, Wu J, Zanoni G, Song JN, Ning Y. Difluorodiazoethane as a masked acetylene equivalent in formal [3 + 2] cycloadditions with ketones to access 2,3-functionalized furans. Org Chem Front 2022. [DOI: 10.1039/d2qo01045c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A transition-metal-free [3+2] cycloaddition of CF2HCHN2 with β-ketones is reported, which enables the synthesis of 2,3-functionalized furans. Sequential defluorination, nucleophilic addition, and cyclization are key elemental steps of the reaction.
Collapse
Affiliation(s)
- Xiaolong Zhang
- Jilin Province Key Laboratory of Organic Functional Molecular Design & Synthesis, Department of Chemistry, Northeast Normal University, Changchun 130024, China
| | - Xin Li
- School of Life Science, Jilin University, Changchun 130012, China
| | - Paramasivam Sivaguru
- Jilin Province Key Laboratory of Organic Functional Molecular Design & Synthesis, Department of Chemistry, Northeast Normal University, Changchun 130024, China
| | - Jiayi Wu
- Jilin Province Key Laboratory of Organic Functional Molecular Design & Synthesis, Department of Chemistry, Northeast Normal University, Changchun 130024, China
| | - Giuseppe Zanoni
- Department of Chemistry, University of Pavia, Viale Taramelli 12, Pavia 27100, Italy
| | - Jin-Na Song
- School of Life Science, Jilin University, Changchun 130012, China
| | - Yongquan Ning
- Jilin Province Key Laboratory of Organic Functional Molecular Design & Synthesis, Department of Chemistry, Northeast Normal University, Changchun 130024, China
| |
Collapse
|
3
|
Xiao J, Peng H, Liang J, Luo X, Cheng X, Su W. Gold‐Catalyzed Tandem Cycloisomerization/Ring Expansion of Alkynyl Spiro‐epoxyoxindoles: Access to Furo[2,3‐c]quinolinone Derivatives. ASIAN J ORG CHEM 2021. [DOI: 10.1002/ajoc.202100202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Jun‐An Xiao
- Guangxi Key Laboratory of Natural Polymer Chemistry and Physics Nanning Normal University Nanning, Guangxi 530001 P. R. China
| | - Hai Peng
- Guangxi Key Laboratory of Natural Polymer Chemistry and Physics Nanning Normal University Nanning, Guangxi 530001 P. R. China
| | - Jin‐Shao Liang
- Guangxi Key Laboratory of Natural Polymer Chemistry and Physics Nanning Normal University Nanning, Guangxi 530001 P. R. China
| | - Xiao‐Yan Luo
- Guangxi Key Laboratory of Natural Polymer Chemistry and Physics Nanning Normal University Nanning, Guangxi 530001 P. R. China
| | - Xiu‐Liang Cheng
- Guangxi Key Laboratory of Natural Polymer Chemistry and Physics Nanning Normal University Nanning, Guangxi 530001 P. R. China
| | - Wei Su
- Guangxi Key Laboratory of Natural Polymer Chemistry and Physics Nanning Normal University Nanning, Guangxi 530001 P. R. China
| |
Collapse
|
4
|
Fyfe TJ, Kellam B, Sykes DA, Capuano B, Scammells PJ, Lane JR, Charlton SJ, Mistry SN. Structure-Kinetic Profiling of Haloperidol Analogues at the Human Dopamine D 2 Receptor. J Med Chem 2019; 62:9488-9520. [PMID: 31580666 DOI: 10.1021/acs.jmedchem.9b00864] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Haloperidol is a typical antipsychotic drug (APD) associated with an increased risk of extrapyramidal side effects (EPSs) and hyperprolactinemia relative to atypical APDs such as clozapine. Both drugs are dopamine D2 receptor (D2R) antagonists, with contrasting kinetic profiles. Haloperidol displays fast association/slow dissociation at the D2R, whereas clozapine exhibits relatively slow association/fast dissociation. Recently, we have provided evidence that slow dissociation from the D2R predicts hyperprolactinemia, whereas fast association predicts EPS. Unfortunately, clozapine can cause severe side effects independent of its D2R action. Our results suggest an optimal kinetic profile for D2R antagonist APDs that avoids EPS. To begin exploring this hypothesis, we conducted a structure-kinetic relationship study of haloperidol and revealed that subtle structural modifications dramatically change binding kinetic rate constants, affording compounds with a clozapine-like kinetic profile. Thus, optimization of these kinetic parameters may allow development of novel APDs based on the haloperidol scaffold with improved side-effect profiles.
Collapse
Affiliation(s)
- Tim J Fyfe
- School of Pharmacy, Centre for Biomolecular Sciences , University of Nottingham , Nottingham NG7 2RD , U.K
| | - Barrie Kellam
- School of Pharmacy, Centre for Biomolecular Sciences , University of Nottingham , Nottingham NG7 2RD , U.K
| | - David A Sykes
- School of Life Sciences, Queen's Medical Centre , University of Nottingham , Nottingham NG7 2UH , U.K.,Centre of Membrane Protein and Receptors , University of Nottingham , Nottingham NG7 2UH , U.K
| | | | | | - J Robert Lane
- School of Life Sciences, Queen's Medical Centre , University of Nottingham , Nottingham NG7 2UH , U.K.,Centre of Membrane Protein and Receptors , University of Nottingham , Nottingham NG7 2UH , U.K
| | - Steven J Charlton
- School of Life Sciences, Queen's Medical Centre , University of Nottingham , Nottingham NG7 2UH , U.K.,Centre of Membrane Protein and Receptors , University of Nottingham , Nottingham NG7 2UH , U.K.,Excellerate Bioscience Ltd., BioCity , Nottingham NG1 1GF , U.K
| | - Shailesh N Mistry
- School of Pharmacy, Centre for Biomolecular Sciences , University of Nottingham , Nottingham NG7 2RD , U.K
| |
Collapse
|
5
|
Leyva-Pérez A, Cabrero-Antonino JR, Rubio-Marqués P, Al-Resayes SI, Corma A. Synthesis of the ortho/meta/para Isomers of Relevant Pharmaceutical Compounds by Coupling a Sonogashira Reaction with a Regioselective Hydration. ACS Catal 2014. [DOI: 10.1021/cs401075z] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Antonio Leyva-Pérez
- Instituto
de Tecnología Química, Universidad Politécnica de Valencia-Consejo Superior de Investigaciones Científicas, Avda.
de los Naranjos s/n, 46022 Valencia, Spain
| | - Jose R. Cabrero-Antonino
- Instituto
de Tecnología Química, Universidad Politécnica de Valencia-Consejo Superior de Investigaciones Científicas, Avda.
de los Naranjos s/n, 46022 Valencia, Spain
| | - Paula Rubio-Marqués
- Instituto
de Tecnología Química, Universidad Politécnica de Valencia-Consejo Superior de Investigaciones Científicas, Avda.
de los Naranjos s/n, 46022 Valencia, Spain
| | - Saud I. Al-Resayes
- Chemistry
Department, College of Science, King Saud University, B.O. BOX 2455, Riyadh 11451, Saudi Arabia
| | - Avelino Corma
- Instituto
de Tecnología Química, Universidad Politécnica de Valencia-Consejo Superior de Investigaciones Científicas, Avda.
de los Naranjos s/n, 46022 Valencia, Spain
| |
Collapse
|
6
|
Peprah K, Zhu XY, Eyunni SVK, Etukala JR, Setola V, Roth BL, Ablordeppey SY. Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol. Bioorg Med Chem 2012; 20:1671-8. [PMID: 22336245 DOI: 10.1016/j.bmc.2012.01.022] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2011] [Revised: 01/02/2012] [Accepted: 01/11/2012] [Indexed: 11/28/2022]
Abstract
Structure-activity relationship studies on 4-(4-(4-chlorophenyl)-1,4-diazepan-1-yl)-1-(4-fluorophenyl)butan-1-one (SYA 013), a homopiperazine analog of haloperidol has resulted in an understanding of the effect of structural modifications on binding affinity at dopamine and serotonin receptor subtypes. Further exploration, using bioisosteric replacement strategies has led to the identification of several new agents including compounds 7, 8, 11 and 12 which satisfy the initial criteria for further exploration as new antipsychotic agents. In addition, compound 18, a D(3) selective tropanol, has been identified as having the potential for further optimization into a useful drug which may combat neuropsychiatric diseases.
Collapse
Affiliation(s)
- Kwakye Peprah
- Division of Basic Pharmaceutical Sciences, Florida A&M University, College of Pharmacy and Pharmaceutical Sciences, Tallahassee, FL 32307, USA
| | | | | | | | | | | | | |
Collapse
|
7
|
Aranda R, Villalba K, Raviña E, Masaguer CF, Brea J, Areias F, Domínguez E, Selent J, López L, Sanz F, Pastor M, Loza MI. Synthesis, Binding Affinity, and Molecular Docking Analysis of New Benzofuranone Derivatives as Potential Antipsychotics. J Med Chem 2008; 51:6085-94. [DOI: 10.1021/jm800602w] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
- Reyes Aranda
- Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, and Departamento de Farmacología, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782 Santiago de Compostela, Spain, and Research Unit on Biomedical Informatics (GRIB), IMIM, Universitat Pompeu Fabra, Dr. Aiguader 88, E-08003 Barcelona, Spain
| | - Karen Villalba
- Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, and Departamento de Farmacología, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782 Santiago de Compostela, Spain, and Research Unit on Biomedical Informatics (GRIB), IMIM, Universitat Pompeu Fabra, Dr. Aiguader 88, E-08003 Barcelona, Spain
| | - Enrique Raviña
- Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, and Departamento de Farmacología, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782 Santiago de Compostela, Spain, and Research Unit on Biomedical Informatics (GRIB), IMIM, Universitat Pompeu Fabra, Dr. Aiguader 88, E-08003 Barcelona, Spain
| | - Christian F. Masaguer
- Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, and Departamento de Farmacología, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782 Santiago de Compostela, Spain, and Research Unit on Biomedical Informatics (GRIB), IMIM, Universitat Pompeu Fabra, Dr. Aiguader 88, E-08003 Barcelona, Spain
| | - José Brea
- Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, and Departamento de Farmacología, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782 Santiago de Compostela, Spain, and Research Unit on Biomedical Informatics (GRIB), IMIM, Universitat Pompeu Fabra, Dr. Aiguader 88, E-08003 Barcelona, Spain
| | - Filipe Areias
- Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, and Departamento de Farmacología, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782 Santiago de Compostela, Spain, and Research Unit on Biomedical Informatics (GRIB), IMIM, Universitat Pompeu Fabra, Dr. Aiguader 88, E-08003 Barcelona, Spain
| | - Eduardo Domínguez
- Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, and Departamento de Farmacología, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782 Santiago de Compostela, Spain, and Research Unit on Biomedical Informatics (GRIB), IMIM, Universitat Pompeu Fabra, Dr. Aiguader 88, E-08003 Barcelona, Spain
| | - Jana Selent
- Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, and Departamento de Farmacología, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782 Santiago de Compostela, Spain, and Research Unit on Biomedical Informatics (GRIB), IMIM, Universitat Pompeu Fabra, Dr. Aiguader 88, E-08003 Barcelona, Spain
| | - Laura López
- Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, and Departamento de Farmacología, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782 Santiago de Compostela, Spain, and Research Unit on Biomedical Informatics (GRIB), IMIM, Universitat Pompeu Fabra, Dr. Aiguader 88, E-08003 Barcelona, Spain
| | - Ferran Sanz
- Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, and Departamento de Farmacología, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782 Santiago de Compostela, Spain, and Research Unit on Biomedical Informatics (GRIB), IMIM, Universitat Pompeu Fabra, Dr. Aiguader 88, E-08003 Barcelona, Spain
| | - Manuel Pastor
- Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, and Departamento de Farmacología, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782 Santiago de Compostela, Spain, and Research Unit on Biomedical Informatics (GRIB), IMIM, Universitat Pompeu Fabra, Dr. Aiguader 88, E-08003 Barcelona, Spain
| | - María I. Loza
- Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, and Departamento de Farmacología, Facultad de Farmacia, Universidad de Santiago de Compostela, E-15782 Santiago de Compostela, Spain, and Research Unit on Biomedical Informatics (GRIB), IMIM, Universitat Pompeu Fabra, Dr. Aiguader 88, E-08003 Barcelona, Spain
| |
Collapse
|
8
|
Brea J, Castro M, Loza MI, Masaguer CF, Raviña E, Dezi C, Pastor M, Sanz F, Cabrero-Castel A, Galán-Rodríguez B, Fernández-Espejo E, Maldonado R, Robledo P. QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine. Neuropharmacology 2006; 51:251-62. [PMID: 16697427 DOI: 10.1016/j.neuropharm.2006.03.021] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2005] [Revised: 03/14/2006] [Accepted: 03/15/2006] [Indexed: 11/26/2022]
Abstract
The aim of the present work was to characterize a lead compound displaying relevant multi-target interactions, and with an in vivo behavioral profile predictive of atypical antipsychotic activity. Synthesis, molecular modeling and in vitro and in vivo pharmacological studies were carried out for 2-[4-(6-fluorobenzisoxazol-3-yl)piperidinyl]methyl-1,2,3,4-tetrahydro-carbazol-4-one (QF2004B), a conformationally constrained butyrophenone analogue. This compound showed a multi-receptor profile with affinities similar to those of clozapine for serotonin (5-HT2A, 5-HT1A, and 5-HT2C), dopamine (D1, D2, D3 and D4), alpha-adrenergic (alpha1, alpha2), muscarinic (M1, M2) and histamine H1 receptors. In addition, QF2004B mirrored the antipsychotic activity and atypical profile of clozapine in a broad battery of in vivo tests including locomotor activity (ED50 = 1.19 mg/kg), apomorphine-induced stereotypies (ED50 = 0.75 mg/kg), catalepsy (ED50 = 2.13 mg/kg), apomorphine- and DOI (2,5-dimethoxy-4-iodoamphetamine)-induced prepulse inhibition (PPI) tests. These results point to QF2004B as a new lead compound with a relevant multi-receptor interaction profile for the discovery and development of new antipsychotics.
Collapse
Affiliation(s)
- José Brea
- Departamento de Farmacología, Universidad de Santiago de Compostela, Santiago de Compostela, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|